一致Ｂ：2020年半年度报告（英文版）.PDF

1、1China NationalAccord Medicines Corporation Ltd.Semi-Annual Report 2020August 20202Section I.Important Notice,Contents and InterpretationBoard of Directors,Supervisory Committee,all directors,supervisors and seniorexecutives of China National Accord Medicines Corporation Ltd.(hereinafterreferred to

2、as the Company)hereby confirm that there are no any fictitiousstatements,misleading statements,or important omissions carried in this report,and shall take all responsibilities,individual and/or joint,for the reality,accuracy and completion of the whole contents.Lin Zhaoxiong,Principal of the Compan

3、y,Gu Guolin,person in charger ofaccounting works and Wang Ying,person in charge of accounting organ(accounting principal)hereby confirm that the Financial Report of Semi-Annual Report 2020 is authentic,accurate and complete.Other directors attending the Meeting for annual report deliberation except

4、forthe followed:Name of director absentTitle for absent directorReasons for absentAttorneyLian WanyongDirectorOfficial businessLi DongjiuThe Company plans not to pay cash dividends,bonus and carry out capitalizingof common reserves.3ContentsSemi-Annual Report 2020.2Section I Important Notice,Content

5、s and Interpretation.2Section II Company Profile and Main Financial Indexes.5Section III Summary of Company Business.9Section IV Discussion andAnalysis of the Operation.13Section V Important Events.33Section VI Changes in shares and particular about shareholders.61Section VII Preferred Stock.66secti

6、on VIII Convertible Bonds.67Section IX Particulars about Directors,Supervisors and Senior Executives.68Section X Corporate bond.69Section XI Financial Report.70Section XII Documents available for reference.3154InterpretationItemsRefers toContentsListed Company,Company,the Company,Sinopharm Accord,th